Business Description

Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Name Current Vs Industry Vs History
Cash-To-Debt 1.85
Equity-to-Asset 0.48
Debt-to-Equity 0.29
Debt-to-EBITDA -0.18
Interest Coverage 5.48
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.93
Distress
Grey
Safe
Beneish M-Score -4.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 13.51
12-1 Month Momentum % -72.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.83
Quick Ratio 1.43
Cash Ratio 0.79
Days Inventory 348.88
Days Sales Outstanding 116.92
Days Payable 150.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -49.4
Shareholder Yield % 40.16

Financials (Next Earnings Date:2024-05-09 Est.)

FRA:DPOA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Assertio Holdings Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 158.41
EPS (TTM) (€) 0
Beta 0
Volatility % 110.47
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % -72.99
52-Week Range (€) 0.55 - 3.04
Shares Outstanding (Mil) 81.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Assertio Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Assertio Holdings Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Assertio Holdings Inc Frequently Asked Questions

What is Assertio Holdings Inc(FRA:DPOA)'s stock price today?
The current price of FRA:DPOA is €0.73. The 52 week high of FRA:DPOA is €3.04 and 52 week low is €0.55.
When is next earnings date of Assertio Holdings Inc(FRA:DPOA)?
The next earnings date of Assertio Holdings Inc(FRA:DPOA) is 2024-05-09 Est..
Does Assertio Holdings Inc(FRA:DPOA) pay dividends? If so, how much?
Assertio Holdings Inc(FRA:DPOA) does not pay dividend.

Press Release

Subject Date
No Press Release